Page last updated: 2024-10-21

phenytoin and Hepatitis C

phenytoin has been researched along with Hepatitis C in 2 studies

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Natali, KM1
Jimenez, HR1
Slim, J1
Strom, SC1
Fisher, RA1
Rubinstein, WS1
Barranger, JA1
Towbin, RB1
Charron, M1
Mieles, L1
Pisarov, LA1
Dorko, K1
Thompson, MT1
Reyes, J1

Other Studies

2 other studies available for phenytoin and Hepatitis C

ArticleYear
When Coadministration Cannot Be Avoided: Real World Experience of Direct Acting Antivirals for the Treatment of Hepatitis C Virus Infection in Patients on First Generation Anticonvulsants.
    Journal of pharmacy practice, 2022, Volume: 35, Issue:3

    Topics: Anticonvulsants; Antiviral Agents; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Phenobarb

2022
Transplantation of human hepatocytes.
    Transplantation proceedings, 1997, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Cell Culture Techniques; Cell Transplantation; Child, Preschool; Female; Hepatic

1997